Pet Cbd Products Market

According to Stratistics MRC, the Global Pet CBD Products Market is accounted for $874.1 million in 2025 and is expected to reach $2,784.6 million by 2032 growing at a CAGR of 18.0% during the forecast period. Pet CBD products are hemp-derived formulations designed to support the health and wellness of companion animals such as dogs and cats. These products contain cannabidiol (CBD), a non-psychoactive compound known for its potential therapeutic benefits, including relief from anxiety, inflammation, pain, and seizures. Available in various forms—such as oils, treats, capsules, chews, and topicals—pet CBD products are formulated to be safe, legal (with less than 0.3% THC), and palatable for animals. They are increasingly used in holistic pet care routines, often under veterinary guidance, to enhance quality of life and manage chronic conditions without intoxicating effects.

Market Dynamics:

Driver:

Pet Humanization & Wellness Trends

The growing trend of pet humanization is a major driver of the pet CBD products market, as owners increasingly seek holistic wellness solutions for their animals. CBD products are viewed as natural alternatives for managing anxiety, pain, and age-related conditions. With pets treated as family members, demand for safe, non-intoxicating, and therapeutic formulations continues to rise. This shift in consumer behavior, supported by increased spending on pet healthcare and wellness, is fueling rapid market expansion across both developed and emerging regions.

Restraint:

Regulatory Ambiguity

Regulatory ambiguity remains a key restraint in the pet CBD products market. Varying legal frameworks across countries and states create uncertainty around product approval, labeling, and distribution. The lack of standardized guidelines for CBD use in animals limits veterinary endorsement and consumer confidence. Additionally, inconsistent enforcement and evolving legislation hinder market entry for new players and complicate expansion strategies. Until clearer regulations are established, this ambiguity will continue to challenge manufacturers, retailers, and pet owners seeking reliable CBD solutions.

Opportunity:

Product Innovation & Branding

Product innovation and branding presents a significant opportunity for growth in the pet CBD market. Companies are developing diverse formats—such as flavored treats, oils, capsules, and topicals—tailored to pet preferences and health needs. Enhanced branding strategies, including transparency in sourcing and third-party testing, build consumer trust and loyalty. As awareness of CBD’s benefits grows, innovative delivery systems and targeted formulations for specific conditions (e.g., joint pain, anxiety) are driving differentiation. This innovation wave is expected to accelerate adoption and expand market reach.

Threat:

Limited Veterinary Endorsement

Limited veterinary endorsement poses a threat to the pet CBD products market, as many professionals remain cautious due to insufficient clinical data and regulatory risks. Without strong support from veterinarians, pet owners may hesitate to adopt CBD products, especially for chronic or serious conditions. This lack of medical validation affects credibility and slows mainstream acceptance. To overcome this barrier, companies must invest in research, education, and partnerships with veterinary institutions to build evidence-based support and encourage responsible usage.

Covid-19 Impact:

The Covid-19 pandemic had a mixed impact on the pet CBD products market. While supply chain disruptions and economic uncertainty initially slowed growth, increased pet adoption and time spent at home boosted interest in wellness solutions. Owners became more attentive to pets’ behavioral and health issues, driving demand for calming and therapeutic CBD products. E-commerce channels flourished during lockdowns, reshaping purchasing habits and expanding access. Post-pandemic recovery continues to support market momentum, with digital platforms and health-conscious consumers sustaining long-term growth.

The CBD isolate segment is expected to be the largest during the forecast period

The CBD isolate segment is expected to account for the largest market share during the forecast period, due to its purity, consistency, and legal compliance. Isolate formulations contain 99% pure CBD, free from THC and other cannabinoids, making them ideal for pet use. These products offer predictable dosing and minimal risk of psychoactive effects, which appeals to cautious pet owners and veterinarians. Their widespread availability across treats, oils, and capsules further supports dominance, especially in regions with strict regulatory standards.

The e-commerce segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the e-commerce segment is predicted to witness the highest growth rate, due to convenience, product variety, and digital awareness. Online platforms offer easy access to CBD products, along with educational content, reviews, and subscription models. The pandemic accelerated digital adoption, and consumers now prefer direct-to-door delivery for pet wellness items. E-commerce also enables niche brands to reach global audiences, bypassing traditional retail barriers. This shift in buying behavior is expected to sustain rapid growth and reshape distribution strategies.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rising pet ownership, growing disposable incomes, and increasing awareness of natural health solutions. Countries like China, Japan, and India are experiencing a surge in pet humanization, driving demand for holistic care products. Expanding e-commerce infrastructure and favorable regulatory developments further enhance market accessibility. Local manufacturers and global brands are investing in product localization and education, positioning Asia Pacific as a key growth hub for pet CBD.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced veterinary infrastructure, strong consumer awareness, and progressive CBD legislation. The U.S. and Canada lead in pet wellness trends, with owners actively seeking natural remedies for anxiety, pain, and aging-related conditions. High disposable incomes and widespread availability of premium products support rapid adoption. Additionally, robust e-commerce networks and increasing veterinary openness to CBD contribute to North America’s position as the fastest-growing regional market.

Key players in the market

Some of the key players in Pet CBD Products Market include Charlotte’s, Medterra, King Kanine, Pet Releaf, Innovet Pet, Green Roads, Honest Paws, cbdMD, Inc., CBDfx, Canna-Pet, Paw CBD, HempMy Pet, HolistaPet, Joy Organics and PureKana.

Key Developments:

In September 2025, The multi-year partnership between Charlotte Hornets and Judi Health marks a strategic alignment of athletic branding and healthcare innovation: Judi Health becomes the exclusive jersey-patch partner for the Hornets, showcasing its healthcare-tech leadership on the NBA stage and amplifying its mission to transform benefit administration across the U.S.

In April 2025, Nutriband Inc. has entered into a partnership agreement with Charlotte FC, leveraging the collaboration to boost its brand visibility—particularly for its “AI Tape” product made in the Charlotte region—and spotlight its AVERSA™ abuse-deterrent patch technology.

Products Covered:
• Oils & Tinctures
• Treats & Chews
• Capsules & Softgels
• Topicals (Balms, Sprays, Creams)
• Supplements

Spectrums Covered:
• Full-Spectrum CBD
• Broad-Spectrum CBD
• CBD Isolate
• Hemp-Derived CBD
• Synthetic - Derived CBD

Pet Types Covered:
• Dogs
• Cats
• Other Pets

Applications Covered:
• Anxiety & Stress Relief
• Pain Management & Inflammation
• Joint Health & Mobility Support
• Skin & Allergies
• Seizure Control
• General Wellness & Immune Support
• Other Applications

Distribution Channels Covered:
• E-commerce
• Pet Specialty Stores
• Veterinary Clinics & Hospitals
• CBD / Hemp-Specialty Stores
• Offline General Retail

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances